Jade Biosciences, Inc

JBIONASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

63.6M

on 2026-06-30, from 27.9M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$600.0M

S-3 of 2026-05-07. 1 prospectus supplement filed under it since. S-3 ↗

$200.0M

Jefferies, agreement of 2026-05-07. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

The 10-Q filed 2026-08-10 is not read yet.

Cash

14.9 quarters

$461.2M on 2026-06-30 ÷ $30.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-03	Public offering	10,000,000	$15.00	$150.0M	424B5 ↗
2025-12-13	Private placement	not read	$14.00	$45.0M	8-K ↗
2025-05-01	Private placement	not read	not read	$334.2M	8-K ↗

Also on file: a 1-for-35 reverse split, 2025-03-25 8-K ↗